第 13 節　皮膚科製劑

Dermatological preparations

• 13.1(刪除)104/6/1
• 13.2Cadexomer iodine如 Iodosorb powder87/4/1
• 13.3Calcipotriol外用製劑109/10/1
  • 13.3.1Calcipotriol外用單方製劑99/12/1
  • 13.3.2含calcipotriol及類固醇之外用複方製劑如 Daivobet、Enstilar115/1/1
  • 13.3.3與tazarotene併用，兩者合計總量每星期不超過30gm或30mL，若因病情需要兩者合併使用量需超過每星期30gm 者，應於病歷詳細記錄理由。99/12/1
• 13.4Isotretinoin口服製劑如 Roaccutane94/3/1
• 13.5Acitretin如 Neotigason87/11/1
• 13.6Methoxsalen製劑87/11/1
• 13.7Doxepin HCl cream如 Ichderm88/6/1
• 13.8Tazarotene外用製劑101/2/1
• 13.9Calcitriol如 Silkis ointment99/12/1
• 13.10Tacrolimus如 Protopic Ointment111/2/1
• 13.11Pimecrolimus (Elidel 1% )111/2/1
• 13.12Amorolfine如 Amocoat99/4/1
• 13.13Podophyllotoxin如 Wart Del Cream102/9/1
• 13.14Ingenol如 Picato105/11/1
• 13.15Permethrin外用製劑113/12/1
• 13.16Ivermectin如 Stromectol113/4/1
• 13.17Dupilumab如 Dupixent、Rinvoq、Cibinqo、Ebglyss115/6/1
  • 13.17.1Dupilumab如 Dupixent、Rinvoq、Cibinqo、Ebglyss115/6/1
  • 13.17.2Dupilumab如 Dupixent113/2/1
• 13.18Nadifloxacin外用製劑如 Nadixa110/6/1
• 13.19Centella asiatica extract, plectranthus amboinicus extract外用製劑如 Fespixon cream112/8/1